• LAST PRICE
    22.1000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 22.1000
  • Day Range
    ---
  • 52 Week Range
    Low 12.5400
    High 28.9100
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 23.1
TimeVolumeBCYC
09:32 ET196722.85
09:34 ET330522.97
09:36 ET122022.9
09:41 ET10023
09:43 ET90023.025
09:52 ET30023.04
09:54 ET10022.98
09:57 ET10022.685
09:59 ET20022.75
10:01 ET15722.845
10:06 ET110022.75
10:08 ET10022.75
10:10 ET10022.75
10:15 ET10022.715
10:19 ET150222.8
10:21 ET10022.8
10:28 ET75022.768
10:35 ET40022.7675
10:39 ET60022.6895
10:44 ET33322.7
10:48 ET50022.73
10:50 ET90022.66
10:51 ET20022.7
10:53 ET10022.71
11:00 ET100022.7
11:02 ET213122.7
11:06 ET320022.7
11:08 ET82322.61
11:11 ET99822.5
11:20 ET97122.4
11:24 ET60022.47
11:26 ET80022.5
11:27 ET91822.5
11:33 ET111522.5
11:36 ET102022.49
11:38 ET89022.38
11:40 ET233922.24
11:42 ET88622.32
11:44 ET10022.14
11:45 ET265022.2
11:47 ET71622.21
11:49 ET100022.3
11:51 ET98422.36
11:54 ET30022.41
11:56 ET60022.37
11:58 ET20022.33
12:00 ET160022.43
12:09 ET10022.35
12:12 ET20022.35
12:14 ET10022.35
12:20 ET129622.42
12:21 ET86822.4
12:23 ET10022.39
12:25 ET50022.39
12:27 ET30022.46
12:30 ET20022.46
12:32 ET10022.4
12:34 ET712322.5
12:39 ET110022.51
12:43 ET60222.3825
12:45 ET40022.3825
12:52 ET10022.36
12:56 ET467322.42
12:57 ET136022.2
12:59 ET134122.2304
01:01 ET50022.2006
01:03 ET24022.11
01:06 ET115022.11
01:08 ET55122.09
01:10 ET27022.165
01:12 ET21022.165
01:15 ET10022.26
01:17 ET49622.2362
01:21 ET785622.23
01:26 ET40022.29
01:28 ET50022.22
01:30 ET70022.285
01:32 ET30022.22
01:33 ET74022.22
01:35 ET30022.205
01:37 ET10022.22
01:39 ET30022.21
01:44 ET42022.195
01:46 ET168822.26
01:48 ET10022.325
01:50 ET10022.25
01:51 ET10022.215
01:53 ET130722.22
01:55 ET130022.3
01:57 ET56122.215
02:00 ET10022.22
02:02 ET10022.22
02:04 ET10022.22
02:08 ET10022.195
02:09 ET60022.43
02:11 ET10022.26
02:18 ET20022.329
02:22 ET247022.215
02:24 ET102022.2125
02:26 ET31022.22
02:27 ET50022.2125
02:31 ET40022.16
02:36 ET30022.16
02:38 ET10022.15
02:40 ET10022.125
02:45 ET40022.1075
02:47 ET116322.11
02:49 ET10022.11
03:00 ET20022.11
03:02 ET247922.11
03:03 ET548522
03:05 ET70021.965
03:07 ET40022.01
03:09 ET103322
03:14 ET14021.9792
03:18 ET60021.97
03:20 ET10021.97
03:21 ET959022
03:25 ET30022.045
03:27 ET20022.09
03:30 ET60022.09
03:32 ET116022
03:34 ET409022.2
03:36 ET143022.19
03:38 ET240022.2
03:39 ET202522.195
03:41 ET160022.2
03:43 ET110022.23
03:45 ET145522.2
03:48 ET180022.2
03:50 ET233422.2
03:52 ET220022.15
03:54 ET40022
03:56 ET181822
03:57 ET83721.97
03:59 ET498522.1
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBCYC
Bicycle Therapeutics PLC
1.6B
-5.0x
---
United StatesKURA
Kura Oncology Inc
1.6B
-9.5x
---
United StatesSYRE
Spyre Therapeutics Inc
1.6B
-0.4x
---
United StatesNMRA
Neumora Therapeutics Inc
1.6B
-6.1x
---
United StatesNAMS
NewAmsterdam Pharma Company NV
1.7B
-6.6x
---
United StatesEWTX
Edgewise Therapeutics Inc
1.6B
-11.3x
---
As of 2024-06-18

Company Information

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. The Company is evaluating BT8009, a Bicycle Toxin Conjugate (BTC) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC targeting EphA2, a historically undruggable target, and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist (Bicycle TICA) targeting Nectin-4 and agonizing CD137, in Company-sponsored clinical trials. Additionally, the Company is developing Bicycle Radio Conjugates (BRC) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle technology to develop therapies for diseases beyond oncology. Its product candidates also include BT1718 and BT7455.

Contact Information

Headquarters
Blocks A & B, Portway Building, Granta PCAMBRIDGE, United Kingdom CB21 6GS
Phone
122-326-1503
Fax
---

Executives

Non-Executive Chairman of the Board
Pierre Legault
Chief Executive Officer, Executive Director
Kevin Lee
Chief Financial Officer, Principal Financial Officer
Alethia Young
Chief Operating Officer
Alistair Milnes
Chief Technology Officer
Michael Skynner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$41.6M
Shares Outstanding
68.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.95
EPS
$-4.45
Book Value
$8.74
P/E Ratio
-5.0x
Price/Sales (TTM)
38.1
Price/Cash Flow (TTM)
---
Operating Margin
-432.25%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.